Group 1 - The company experienced poor performance in Q2 last year and an even worse sequential decline in Q2 this year despite significant marketing expenditures [1] - The company aims to enhance brand awareness, expand market share, and improve product competitiveness through its marketing investments [1] - The board of directors emphasizes the importance of market capitalization management and has implemented a trial market capitalization management system [1] Group 2 - The company has positioned its brand as "Guangyuyuan National Medicine, Premium Health Products" and has tailored strategies for different products and channels [1] - The company assures that all operations are proceeding normally and production activities are on track [1] - The company encourages stakeholders to pay attention to official announcements regarding the appointment of directors and senior management personnel [1]